Pharma & Healthcare
Innovative Small Molecule Targeted Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 05, 24
- ID: 660680
- Pages: 132
- Figures: 253
- Views: 7
The global market for Innovative Small Molecule Targeted Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Innovative Small Molecule Targeted Drugs was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Innovative Small Molecule Targeted Drugs was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Innovative Small Molecule Targeted Drugs was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Innovative Small Molecule Targeted Drugs include Roche, Pfizer, Genetech, Novartis, Bayer, Abbive, Jiangsu Hengrui Pharmaceuticals, Jiangsu Chia Tai-Tianqing Pharmaceutical and QILU Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Innovative Small Molecule Targeted Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Innovative Small Molecule Targeted Drugs by region & country, by Type, and by Application.
The Innovative Small Molecule Targeted Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Innovative Small Molecule Targeted Drugs.
Market Segmentation
By Company
Roche
Pfizer
Genetech
Novartis
Bayer
Abbive
Jiangsu Hengrui Pharmaceuticals
Jiangsu Chia Tai-Tianqing Pharmaceutical
QILU Pharmaceutical
Betta Pharmaceuticals
Shanghai Junshi Biosciences
Shanghai Allist Pharmaceuticals
Shenzhen Chipscreen Biosciences
Innovent Biologics, Inc.
Hinova Pharmaceuticals
Segment by Type:
Kinase Inhibitors
Epigenetic Inhibitors
Proteasome Inhibitor
Segment by Application
Hospital
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Innovative Small Molecule Targeted Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Innovative Small Molecule Targeted Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Innovative Small Molecule Targeted Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Innovative Small Molecule Targeted Drugs was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Innovative Small Molecule Targeted Drugs was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Innovative Small Molecule Targeted Drugs was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Innovative Small Molecule Targeted Drugs include Roche, Pfizer, Genetech, Novartis, Bayer, Abbive, Jiangsu Hengrui Pharmaceuticals, Jiangsu Chia Tai-Tianqing Pharmaceutical and QILU Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Innovative Small Molecule Targeted Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Innovative Small Molecule Targeted Drugs by region & country, by Type, and by Application.
The Innovative Small Molecule Targeted Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Innovative Small Molecule Targeted Drugs.
Market Segmentation
By Company
Roche
Pfizer
Genetech
Novartis
Bayer
Abbive
Jiangsu Hengrui Pharmaceuticals
Jiangsu Chia Tai-Tianqing Pharmaceutical
QILU Pharmaceutical
Betta Pharmaceuticals
Shanghai Junshi Biosciences
Shanghai Allist Pharmaceuticals
Shenzhen Chipscreen Biosciences
Innovent Biologics, Inc.
Hinova Pharmaceuticals
Segment by Type:
Kinase Inhibitors
Epigenetic Inhibitors
Proteasome Inhibitor
Segment by Application
Hospital
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Innovative Small Molecule Targeted Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Innovative Small Molecule Targeted Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Innovative Small Molecule Targeted Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Innovative Small Molecule Targeted Drugs Product Introduction
1.2 Global Innovative Small Molecule Targeted Drugs Market Size Forecast
1.2.1 Global Innovative Small Molecule Targeted Drugs Sales Value (2019-2030)
1.2.2 Global Innovative Small Molecule Targeted Drugs Sales Volume (2019-2030)
1.2.3 Global Innovative Small Molecule Targeted Drugs Sales Price (2019-2030)
1.3 Innovative Small Molecule Targeted Drugs Market Trends & Drivers
1.3.1 Innovative Small Molecule Targeted Drugs Industry Trends
1.3.2 Innovative Small Molecule Targeted Drugs Market Drivers & Opportunity
1.3.3 Innovative Small Molecule Targeted Drugs Market Challenges
1.3.4 Innovative Small Molecule Targeted Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Innovative Small Molecule Targeted Drugs Players Revenue Ranking (2023)
2.2 Global Innovative Small Molecule Targeted Drugs Revenue by Company (2019-2024)
2.3 Global Innovative Small Molecule Targeted Drugs Players Sales Volume Ranking (2023)
2.4 Global Innovative Small Molecule Targeted Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Innovative Small Molecule Targeted Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Innovative Small Molecule Targeted Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Innovative Small Molecule Targeted Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Innovative Small Molecule Targeted Drugs
2.9 Innovative Small Molecule Targeted Drugs Market Competitive Analysis
2.9.1 Innovative Small Molecule Targeted Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Innovative Small Molecule Targeted Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Small Molecule Targeted Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Kinase Inhibitors
3.1.2 Epigenetic Inhibitors
3.1.3 Proteasome Inhibitor
3.2 Global Innovative Small Molecule Targeted Drugs Sales Value by Type
3.2.1 Global Innovative Small Molecule Targeted Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Innovative Small Molecule Targeted Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Innovative Small Molecule Targeted Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Innovative Small Molecule Targeted Drugs Sales Volume by Type
3.3.1 Global Innovative Small Molecule Targeted Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Innovative Small Molecule Targeted Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Innovative Small Molecule Targeted Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Innovative Small Molecule Targeted Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Innovative Small Molecule Targeted Drugs Sales Value by Application
4.2.1 Global Innovative Small Molecule Targeted Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Innovative Small Molecule Targeted Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Innovative Small Molecule Targeted Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Innovative Small Molecule Targeted Drugs Sales Volume by Application
4.3.1 Global Innovative Small Molecule Targeted Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Innovative Small Molecule Targeted Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Innovative Small Molecule Targeted Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Innovative Small Molecule Targeted Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Innovative Small Molecule Targeted Drugs Sales Value by Region
5.1.1 Global Innovative Small Molecule Targeted Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2019-2024)
5.1.3 Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2025-2030)
5.1.4 Global Innovative Small Molecule Targeted Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region
5.2.1 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Innovative Small Molecule Targeted Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.4.2 North America Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.5.2 Europe Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.7.2 South America Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value
6.2.1 Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.3.2 United States Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.4.2 Europe Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.5.2 China Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.6.2 Japan Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.7.2 South Korea Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.9.2 India Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Innovative Small Molecule Targeted Drugs Product Offerings
7.1.5 Roche Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Pfizer Innovative Small Molecule Targeted Drugs Product Offerings
7.2.5 Pfizer Recent Development
7.3 Genetech
7.3.1 Genetech Company Information
7.3.2 Genetech Introduction and Business Overview
7.3.3 Genetech Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Genetech Innovative Small Molecule Targeted Drugs Product Offerings
7.3.5 Genetech Recent Development
7.4 Novartis
7.4.1 Novartis Company Information
7.4.2 Novartis Introduction and Business Overview
7.4.3 Novartis Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Novartis Innovative Small Molecule Targeted Drugs Product Offerings
7.4.5 Novartis Recent Development
7.5 Bayer
7.5.1 Bayer Company Information
7.5.2 Bayer Introduction and Business Overview
7.5.3 Bayer Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bayer Innovative Small Molecule Targeted Drugs Product Offerings
7.5.5 Bayer Recent Development
7.6 Abbive
7.6.1 Abbive Company Information
7.6.2 Abbive Introduction and Business Overview
7.6.3 Abbive Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Abbive Innovative Small Molecule Targeted Drugs Product Offerings
7.6.5 Abbive Recent Development
7.7 Jiangsu Hengrui Pharmaceuticals
7.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
7.7.2 Jiangsu Hengrui Pharmaceuticals Introduction and Business Overview
7.7.3 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
7.7.5 Jiangsu Hengrui Pharmaceuticals Recent Development
7.8 Jiangsu Chia Tai-Tianqing Pharmaceutical
7.8.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
7.8.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Introduction and Business Overview
7.8.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product Offerings
7.8.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Development
7.9 QILU Pharmaceutical
7.9.1 QILU Pharmaceutical Company Information
7.9.2 QILU Pharmaceutical Introduction and Business Overview
7.9.3 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product Offerings
7.9.5 QILU Pharmaceutical Recent Development
7.10 Betta Pharmaceuticals
7.10.1 Betta Pharmaceuticals Company Information
7.10.2 Betta Pharmaceuticals Introduction and Business Overview
7.10.3 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
7.10.5 Betta Pharmaceuticals Recent Development
7.11 Shanghai Junshi Biosciences
7.11.1 Shanghai Junshi Biosciences Company Information
7.11.2 Shanghai Junshi Biosciences Introduction and Business Overview
7.11.3 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product Offerings
7.11.5 Shanghai Junshi Biosciences Recent Development
7.12 Shanghai Allist Pharmaceuticals
7.12.1 Shanghai Allist Pharmaceuticals Company Information
7.12.2 Shanghai Allist Pharmaceuticals Introduction and Business Overview
7.12.3 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
7.12.5 Shanghai Allist Pharmaceuticals Recent Development
7.13 Shenzhen Chipscreen Biosciences
7.13.1 Shenzhen Chipscreen Biosciences Company Information
7.13.2 Shenzhen Chipscreen Biosciences Introduction and Business Overview
7.13.3 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product Offerings
7.13.5 Shenzhen Chipscreen Biosciences Recent Development
7.14 Innovent Biologics, Inc.
7.14.1 Innovent Biologics, Inc. Company Information
7.14.2 Innovent Biologics, Inc. Introduction and Business Overview
7.14.3 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product Offerings
7.14.5 Innovent Biologics, Inc. Recent Development
7.15 Hinova Pharmaceuticals
7.15.1 Hinova Pharmaceuticals Company Information
7.15.2 Hinova Pharmaceuticals Introduction and Business Overview
7.15.3 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
7.15.5 Hinova Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Innovative Small Molecule Targeted Drugs Industrial Chain
8.2 Innovative Small Molecule Targeted Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Innovative Small Molecule Targeted Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Innovative Small Molecule Targeted Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Innovative Small Molecule Targeted Drugs Product Introduction
1.2 Global Innovative Small Molecule Targeted Drugs Market Size Forecast
1.2.1 Global Innovative Small Molecule Targeted Drugs Sales Value (2019-2030)
1.2.2 Global Innovative Small Molecule Targeted Drugs Sales Volume (2019-2030)
1.2.3 Global Innovative Small Molecule Targeted Drugs Sales Price (2019-2030)
1.3 Innovative Small Molecule Targeted Drugs Market Trends & Drivers
1.3.1 Innovative Small Molecule Targeted Drugs Industry Trends
1.3.2 Innovative Small Molecule Targeted Drugs Market Drivers & Opportunity
1.3.3 Innovative Small Molecule Targeted Drugs Market Challenges
1.3.4 Innovative Small Molecule Targeted Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Innovative Small Molecule Targeted Drugs Players Revenue Ranking (2023)
2.2 Global Innovative Small Molecule Targeted Drugs Revenue by Company (2019-2024)
2.3 Global Innovative Small Molecule Targeted Drugs Players Sales Volume Ranking (2023)
2.4 Global Innovative Small Molecule Targeted Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Innovative Small Molecule Targeted Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Innovative Small Molecule Targeted Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Innovative Small Molecule Targeted Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Innovative Small Molecule Targeted Drugs
2.9 Innovative Small Molecule Targeted Drugs Market Competitive Analysis
2.9.1 Innovative Small Molecule Targeted Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Innovative Small Molecule Targeted Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Small Molecule Targeted Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Kinase Inhibitors
3.1.2 Epigenetic Inhibitors
3.1.3 Proteasome Inhibitor
3.2 Global Innovative Small Molecule Targeted Drugs Sales Value by Type
3.2.1 Global Innovative Small Molecule Targeted Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Innovative Small Molecule Targeted Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Innovative Small Molecule Targeted Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Innovative Small Molecule Targeted Drugs Sales Volume by Type
3.3.1 Global Innovative Small Molecule Targeted Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Innovative Small Molecule Targeted Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Innovative Small Molecule Targeted Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Innovative Small Molecule Targeted Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Innovative Small Molecule Targeted Drugs Sales Value by Application
4.2.1 Global Innovative Small Molecule Targeted Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Innovative Small Molecule Targeted Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Innovative Small Molecule Targeted Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Innovative Small Molecule Targeted Drugs Sales Volume by Application
4.3.1 Global Innovative Small Molecule Targeted Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Innovative Small Molecule Targeted Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Innovative Small Molecule Targeted Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Innovative Small Molecule Targeted Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Innovative Small Molecule Targeted Drugs Sales Value by Region
5.1.1 Global Innovative Small Molecule Targeted Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2019-2024)
5.1.3 Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2025-2030)
5.1.4 Global Innovative Small Molecule Targeted Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region
5.2.1 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Innovative Small Molecule Targeted Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.4.2 North America Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.5.2 Europe Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.7.2 South America Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value
6.2.1 Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.3.2 United States Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.4.2 Europe Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.5.2 China Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.6.2 Japan Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.7.2 South Korea Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Innovative Small Molecule Targeted Drugs Sales Value, 2019-2030
6.9.2 India Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Innovative Small Molecule Targeted Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Innovative Small Molecule Targeted Drugs Product Offerings
7.1.5 Roche Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Pfizer Innovative Small Molecule Targeted Drugs Product Offerings
7.2.5 Pfizer Recent Development
7.3 Genetech
7.3.1 Genetech Company Information
7.3.2 Genetech Introduction and Business Overview
7.3.3 Genetech Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Genetech Innovative Small Molecule Targeted Drugs Product Offerings
7.3.5 Genetech Recent Development
7.4 Novartis
7.4.1 Novartis Company Information
7.4.2 Novartis Introduction and Business Overview
7.4.3 Novartis Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Novartis Innovative Small Molecule Targeted Drugs Product Offerings
7.4.5 Novartis Recent Development
7.5 Bayer
7.5.1 Bayer Company Information
7.5.2 Bayer Introduction and Business Overview
7.5.3 Bayer Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bayer Innovative Small Molecule Targeted Drugs Product Offerings
7.5.5 Bayer Recent Development
7.6 Abbive
7.6.1 Abbive Company Information
7.6.2 Abbive Introduction and Business Overview
7.6.3 Abbive Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Abbive Innovative Small Molecule Targeted Drugs Product Offerings
7.6.5 Abbive Recent Development
7.7 Jiangsu Hengrui Pharmaceuticals
7.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
7.7.2 Jiangsu Hengrui Pharmaceuticals Introduction and Business Overview
7.7.3 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
7.7.5 Jiangsu Hengrui Pharmaceuticals Recent Development
7.8 Jiangsu Chia Tai-Tianqing Pharmaceutical
7.8.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
7.8.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Introduction and Business Overview
7.8.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product Offerings
7.8.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Development
7.9 QILU Pharmaceutical
7.9.1 QILU Pharmaceutical Company Information
7.9.2 QILU Pharmaceutical Introduction and Business Overview
7.9.3 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product Offerings
7.9.5 QILU Pharmaceutical Recent Development
7.10 Betta Pharmaceuticals
7.10.1 Betta Pharmaceuticals Company Information
7.10.2 Betta Pharmaceuticals Introduction and Business Overview
7.10.3 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
7.10.5 Betta Pharmaceuticals Recent Development
7.11 Shanghai Junshi Biosciences
7.11.1 Shanghai Junshi Biosciences Company Information
7.11.2 Shanghai Junshi Biosciences Introduction and Business Overview
7.11.3 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product Offerings
7.11.5 Shanghai Junshi Biosciences Recent Development
7.12 Shanghai Allist Pharmaceuticals
7.12.1 Shanghai Allist Pharmaceuticals Company Information
7.12.2 Shanghai Allist Pharmaceuticals Introduction and Business Overview
7.12.3 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
7.12.5 Shanghai Allist Pharmaceuticals Recent Development
7.13 Shenzhen Chipscreen Biosciences
7.13.1 Shenzhen Chipscreen Biosciences Company Information
7.13.2 Shenzhen Chipscreen Biosciences Introduction and Business Overview
7.13.3 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product Offerings
7.13.5 Shenzhen Chipscreen Biosciences Recent Development
7.14 Innovent Biologics, Inc.
7.14.1 Innovent Biologics, Inc. Company Information
7.14.2 Innovent Biologics, Inc. Introduction and Business Overview
7.14.3 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product Offerings
7.14.5 Innovent Biologics, Inc. Recent Development
7.15 Hinova Pharmaceuticals
7.15.1 Hinova Pharmaceuticals Company Information
7.15.2 Hinova Pharmaceuticals Introduction and Business Overview
7.15.3 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
7.15.5 Hinova Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Innovative Small Molecule Targeted Drugs Industrial Chain
8.2 Innovative Small Molecule Targeted Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Innovative Small Molecule Targeted Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Innovative Small Molecule Targeted Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Innovative Small Molecule Targeted Drugs Market Trends
Table 2. Innovative Small Molecule Targeted Drugs Market Drivers & Opportunity
Table 3. Innovative Small Molecule Targeted Drugs Market Challenges
Table 4. Innovative Small Molecule Targeted Drugs Market Restraints
Table 5. Global Innovative Small Molecule Targeted Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Innovative Small Molecule Targeted Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Innovative Small Molecule Targeted Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Innovative Small Molecule Targeted Drugs Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Innovative Small Molecule Targeted Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Innovative Small Molecule Targeted Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Innovative Small Molecule Targeted Drugs
Table 13. Global Innovative Small Molecule Targeted Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Small Molecule Targeted Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Innovative Small Molecule Targeted Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Innovative Small Molecule Targeted Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Innovative Small Molecule Targeted Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Innovative Small Molecule Targeted Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Innovative Small Molecule Targeted Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Innovative Small Molecule Targeted Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Innovative Small Molecule Targeted Drugs Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Innovative Small Molecule Targeted Drugs Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Innovative Small Molecule Targeted Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Innovative Small Molecule Targeted Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Innovative Small Molecule Targeted Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Innovative Small Molecule Targeted Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Innovative Small Molecule Targeted Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Innovative Small Molecule Targeted Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Innovative Small Molecule Targeted Drugs Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Innovative Small Molecule Targeted Drugs Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Innovative Small Molecule Targeted Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Innovative Small Molecule Targeted Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Innovative Small Molecule Targeted Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Roche Company Information
Table 58. Roche Introduction and Business Overview
Table 59. Roche Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Roche Innovative Small Molecule Targeted Drugs Product Offerings
Table 61. Roche Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Pfizer Innovative Small Molecule Targeted Drugs Product Offerings
Table 66. Pfizer Recent Development
Table 67. Genetech Company Information
Table 68. Genetech Introduction and Business Overview
Table 69. Genetech Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Genetech Innovative Small Molecule Targeted Drugs Product Offerings
Table 71. Genetech Recent Development
Table 72. Novartis Company Information
Table 73. Novartis Introduction and Business Overview
Table 74. Novartis Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Novartis Innovative Small Molecule Targeted Drugs Product Offerings
Table 76. Novartis Recent Development
Table 77. Bayer Company Information
Table 78. Bayer Introduction and Business Overview
Table 79. Bayer Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Bayer Innovative Small Molecule Targeted Drugs Product Offerings
Table 81. Bayer Recent Development
Table 82. Abbive Company Information
Table 83. Abbive Introduction and Business Overview
Table 84. Abbive Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Abbive Innovative Small Molecule Targeted Drugs Product Offerings
Table 86. Abbive Recent Development
Table 87. Jiangsu Hengrui Pharmaceuticals Company Information
Table 88. Jiangsu Hengrui Pharmaceuticals Introduction and Business Overview
Table 89. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
Table 91. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 92. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
Table 93. Jiangsu Chia Tai-Tianqing Pharmaceutical Introduction and Business Overview
Table 94. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product Offerings
Table 96. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Development
Table 97. QILU Pharmaceutical Company Information
Table 98. QILU Pharmaceutical Introduction and Business Overview
Table 99. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product Offerings
Table 101. QILU Pharmaceutical Recent Development
Table 102. Betta Pharmaceuticals Company Information
Table 103. Betta Pharmaceuticals Introduction and Business Overview
Table 104. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
Table 106. Betta Pharmaceuticals Recent Development
Table 107. Shanghai Junshi Biosciences Company Information
Table 108. Shanghai Junshi Biosciences Introduction and Business Overview
Table 109. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product Offerings
Table 111. Shanghai Junshi Biosciences Recent Development
Table 112. Shanghai Allist Pharmaceuticals Company Information
Table 113. Shanghai Allist Pharmaceuticals Introduction and Business Overview
Table 114. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
Table 116. Shanghai Allist Pharmaceuticals Recent Development
Table 117. Shenzhen Chipscreen Biosciences Company Information
Table 118. Shenzhen Chipscreen Biosciences Introduction and Business Overview
Table 119. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product Offerings
Table 121. Shenzhen Chipscreen Biosciences Recent Development
Table 122. Innovent Biologics, Inc. Company Information
Table 123. Innovent Biologics, Inc. Introduction and Business Overview
Table 124. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product Offerings
Table 126. Innovent Biologics, Inc. Recent Development
Table 127. Hinova Pharmaceuticals Company Information
Table 128. Hinova Pharmaceuticals Introduction and Business Overview
Table 129. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
Table 131. Hinova Pharmaceuticals Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Innovative Small Molecule Targeted Drugs Downstream Customers
Table 135. Innovative Small Molecule Targeted Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Innovative Small Molecule Targeted Drugs Product Picture
Figure 2. Global Innovative Small Molecule Targeted Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Innovative Small Molecule Targeted Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Innovative Small Molecule Targeted Drugs Sales Price (2019-2030) & (US$/Unit)
Figure 6. Innovative Small Molecule Targeted Drugs Report Years Considered
Figure 7. Global Innovative Small Molecule Targeted Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Innovative Small Molecule Targeted Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Innovative Small Molecule Targeted Drugs Revenue in 2023
Figure 10. Innovative Small Molecule Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Kinase Inhibitors Picture
Figure 12. Epigenetic Inhibitors Picture
Figure 13. Proteasome Inhibitor Picture
Figure 14. Global Innovative Small Molecule Targeted Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Innovative Small Molecule Targeted Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Innovative Small Molecule Targeted Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Innovative Small Molecule Targeted Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Innovative Small Molecule Targeted Drugs Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Pharmacy
Figure 21. Global Innovative Small Molecule Targeted Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Innovative Small Molecule Targeted Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Innovative Small Molecule Targeted Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Innovative Small Molecule Targeted Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Innovative Small Molecule Targeted Drugs Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Volume (%), (2019-2030)
Figure 38. United States Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. China Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. China Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 56. India Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 58. India Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 59. Innovative Small Molecule Targeted Drugs Industrial Chain
Figure 60. Innovative Small Molecule Targeted Drugs Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Innovative Small Molecule Targeted Drugs Market Trends
Table 2. Innovative Small Molecule Targeted Drugs Market Drivers & Opportunity
Table 3. Innovative Small Molecule Targeted Drugs Market Challenges
Table 4. Innovative Small Molecule Targeted Drugs Market Restraints
Table 5. Global Innovative Small Molecule Targeted Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Innovative Small Molecule Targeted Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Innovative Small Molecule Targeted Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Innovative Small Molecule Targeted Drugs Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Innovative Small Molecule Targeted Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Innovative Small Molecule Targeted Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Innovative Small Molecule Targeted Drugs
Table 13. Global Innovative Small Molecule Targeted Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Small Molecule Targeted Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Innovative Small Molecule Targeted Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Innovative Small Molecule Targeted Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Innovative Small Molecule Targeted Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Innovative Small Molecule Targeted Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Innovative Small Molecule Targeted Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Innovative Small Molecule Targeted Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Innovative Small Molecule Targeted Drugs Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Innovative Small Molecule Targeted Drugs Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Innovative Small Molecule Targeted Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Innovative Small Molecule Targeted Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Innovative Small Molecule Targeted Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Innovative Small Molecule Targeted Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Innovative Small Molecule Targeted Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Innovative Small Molecule Targeted Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Innovative Small Molecule Targeted Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Innovative Small Molecule Targeted Drugs Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Innovative Small Molecule Targeted Drugs Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Innovative Small Molecule Targeted Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Innovative Small Molecule Targeted Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Innovative Small Molecule Targeted Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Innovative Small Molecule Targeted Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Innovative Small Molecule Targeted Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Roche Company Information
Table 58. Roche Introduction and Business Overview
Table 59. Roche Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Roche Innovative Small Molecule Targeted Drugs Product Offerings
Table 61. Roche Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Pfizer Innovative Small Molecule Targeted Drugs Product Offerings
Table 66. Pfizer Recent Development
Table 67. Genetech Company Information
Table 68. Genetech Introduction and Business Overview
Table 69. Genetech Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Genetech Innovative Small Molecule Targeted Drugs Product Offerings
Table 71. Genetech Recent Development
Table 72. Novartis Company Information
Table 73. Novartis Introduction and Business Overview
Table 74. Novartis Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Novartis Innovative Small Molecule Targeted Drugs Product Offerings
Table 76. Novartis Recent Development
Table 77. Bayer Company Information
Table 78. Bayer Introduction and Business Overview
Table 79. Bayer Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Bayer Innovative Small Molecule Targeted Drugs Product Offerings
Table 81. Bayer Recent Development
Table 82. Abbive Company Information
Table 83. Abbive Introduction and Business Overview
Table 84. Abbive Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Abbive Innovative Small Molecule Targeted Drugs Product Offerings
Table 86. Abbive Recent Development
Table 87. Jiangsu Hengrui Pharmaceuticals Company Information
Table 88. Jiangsu Hengrui Pharmaceuticals Introduction and Business Overview
Table 89. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
Table 91. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 92. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
Table 93. Jiangsu Chia Tai-Tianqing Pharmaceutical Introduction and Business Overview
Table 94. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product Offerings
Table 96. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Development
Table 97. QILU Pharmaceutical Company Information
Table 98. QILU Pharmaceutical Introduction and Business Overview
Table 99. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product Offerings
Table 101. QILU Pharmaceutical Recent Development
Table 102. Betta Pharmaceuticals Company Information
Table 103. Betta Pharmaceuticals Introduction and Business Overview
Table 104. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
Table 106. Betta Pharmaceuticals Recent Development
Table 107. Shanghai Junshi Biosciences Company Information
Table 108. Shanghai Junshi Biosciences Introduction and Business Overview
Table 109. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product Offerings
Table 111. Shanghai Junshi Biosciences Recent Development
Table 112. Shanghai Allist Pharmaceuticals Company Information
Table 113. Shanghai Allist Pharmaceuticals Introduction and Business Overview
Table 114. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
Table 116. Shanghai Allist Pharmaceuticals Recent Development
Table 117. Shenzhen Chipscreen Biosciences Company Information
Table 118. Shenzhen Chipscreen Biosciences Introduction and Business Overview
Table 119. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product Offerings
Table 121. Shenzhen Chipscreen Biosciences Recent Development
Table 122. Innovent Biologics, Inc. Company Information
Table 123. Innovent Biologics, Inc. Introduction and Business Overview
Table 124. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product Offerings
Table 126. Innovent Biologics, Inc. Recent Development
Table 127. Hinova Pharmaceuticals Company Information
Table 128. Hinova Pharmaceuticals Introduction and Business Overview
Table 129. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Offerings
Table 131. Hinova Pharmaceuticals Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Innovative Small Molecule Targeted Drugs Downstream Customers
Table 135. Innovative Small Molecule Targeted Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Innovative Small Molecule Targeted Drugs Product Picture
Figure 2. Global Innovative Small Molecule Targeted Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Innovative Small Molecule Targeted Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Innovative Small Molecule Targeted Drugs Sales Price (2019-2030) & (US$/Unit)
Figure 6. Innovative Small Molecule Targeted Drugs Report Years Considered
Figure 7. Global Innovative Small Molecule Targeted Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Innovative Small Molecule Targeted Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Innovative Small Molecule Targeted Drugs Revenue in 2023
Figure 10. Innovative Small Molecule Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Kinase Inhibitors Picture
Figure 12. Epigenetic Inhibitors Picture
Figure 13. Proteasome Inhibitor Picture
Figure 14. Global Innovative Small Molecule Targeted Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Innovative Small Molecule Targeted Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Innovative Small Molecule Targeted Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Innovative Small Molecule Targeted Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Innovative Small Molecule Targeted Drugs Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Pharmacy
Figure 21. Global Innovative Small Molecule Targeted Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Innovative Small Molecule Targeted Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Innovative Small Molecule Targeted Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Innovative Small Molecule Targeted Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Innovative Small Molecule Targeted Drugs Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Innovative Small Molecule Targeted Drugs Sales Volume (%), (2019-2030)
Figure 38. United States Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. China Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. China Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 56. India Innovative Small Molecule Targeted Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Innovative Small Molecule Targeted Drugs Sales Value by Type (%), 2023 VS 2030
Figure 58. India Innovative Small Molecule Targeted Drugs Sales Value by Application (%), 2023 VS 2030
Figure 59. Innovative Small Molecule Targeted Drugs Industrial Chain
Figure 60. Innovative Small Molecule Targeted Drugs Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232